RAC1 and cancer: In addition to its activation of NF-κB, RAC1 has been implicated in the resistance of cancer cells to radiation therapies through the associated downstream activation of ERK1/2 (extracellular-signal-regulated kinase), elevated expression of anti-apoptotic Bcl-2 family proteins, and decreased pro-apoptotic Bid and Bad proteins [6].